These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 12583608)

  • 21. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
    Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
    Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placentation abnormalities in the pathophysiology of preeclampsia.
    Cheng MH; Wang PH
    Expert Rev Mol Diagn; 2009 Jan; 9(1):37-49. PubMed ID: 19099348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia.
    Walsh SW
    Semin Reprod Endocrinol; 1998; 16(1):93-104. PubMed ID: 9654611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preeclampsia: recent insights.
    Roberts JM; Gammill HS
    Hypertension; 2005 Dec; 46(6):1243-9. PubMed ID: 16230510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipids and vascular dysfunction in preeclampsia.
    Lorentzen B; Henriksen T
    Semin Reprod Endocrinol; 1998; 16(1):33-9. PubMed ID: 9654605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction in preeclampsia.
    Roberts JM
    Semin Reprod Endocrinol; 1998; 16(1):5-15. PubMed ID: 9654603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endocrinology of pre-eclampsia.
    Page NM
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):413-23. PubMed ID: 12354123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
    Boulanger H; Flamant M
    Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction.
    Tomimatsu T; Mimura K; Endo M; Kumasawa K; Kimura T
    Hypertens Res; 2017 Apr; 40(4):305-310. PubMed ID: 27829661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A leading role for the immune system in the pathophysiology of preeclampsia.
    Laresgoiti-Servitje E
    J Leukoc Biol; 2013 Aug; 94(2):247-57. PubMed ID: 23633414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of arterial impairment in preeclampsia: should the paradigm shift?
    Pereira MM; Torrado J; Sosa C; Zócalo Y; Bia D
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H2011-H2030. PubMed ID: 33797272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental oxidative stress: from miscarriage to preeclampsia.
    Burton GJ; Jauniaux E
    J Soc Gynecol Investig; 2004 Sep; 11(6):342-52. PubMed ID: 15350246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The pathophysiology of preeclampsia in view of the two-stage model].
    Alasztics B; Kukor Z; Pánczél Z; Valent S
    Orv Hetil; 2012 Jul; 153(30):1167-76. PubMed ID: 22835633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Observations on pe-eclampsia-eclampsia and the advances in the evolution of some laboratory tests].
    Noguera Sánchez MF; Ayala Barahona T; Arredondo Soberón F; Morgan MA
    Ginecol Obstet Mex; 1997 Jul; 65():300-4. PubMed ID: 9312519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preeclampsia: pathophysiology and practice considerations for the consulting nephrologist.
    Isler CM; Martin JN
    Semin Nephrol; 2002 Jan; 22(1):54-64. PubMed ID: 11785069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of placenta in preeclampsia.
    Myatt L
    Endocrine; 2002 Oct; 19(1):103-11. PubMed ID: 12583607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of preeclampsia.
    Myatt L; Miodovnik M
    Semin Perinatol; 1999 Feb; 23(1):45-57. PubMed ID: 10102170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia.
    Morton JS; Abdalvand A; Jiang Y; Sawamura T; Uwiera RR; Davidge ST
    Hypertension; 2012 May; 59(5):1014-20. PubMed ID: 22392901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.